Expanding medical cannabis on NHS could provide £13.3bn boost for Britain, study reports
Share this @internewscast.com

A recent report reveals that the UK economy might gain a £13.3 billion uplift over ten years by increasing NHS access to medical cannabis, which could help thousands return to work and improve health outcomes. Conducted by the Centre for Economics and Business Research in collaboration with Curaleaf Clinic, the study indicates that broader use of cannabis-based medicine could significantly enhance health conditions.

Examining UK data on chronic illness, employment, and hospital admissions, along with insights from countries such as Germany, suggests that enhanced access could help many individuals with chronic health issues re-enter the workforce and potentially reduce hospital admissions by approximately 28% annually for those eligible.

The economic analysis forecasts that extending NHS access to medical cannabis might generate £1.3 billion per year by facilitating the return of individuals to their jobs, leading to an increase of £4.5 billion in Gross Value Added (GVA) over five years, and reaching £13.3 billion over a decade.

Since its legalisation in 2018, private cannabis prescriptions are reported to have already generated around £283 million in GVA by aiding individuals in recovery and work reintegration.

Data from the previous year by the Office for National Statistics highlighted unprecedented levels of chronic illness, with 7% of the working-age population being sidelined from work.

For two-thirds of those unable to work due to long-term health issues, all conventional treatment avenues have been exhausted, resulting in feelings of helplessness, reduced self-worth, and diminished mental health.

Dr Simon Erridge, director of research at Curaleaf Clinic, said: “As a doctor, I see daily how chronic illness doesn’t just affect someone’s health. It removes them from the workforce, creates economic hardship, and leads to a cascade of social and psychological problems that can worsen the cycle of ill health.”

He said the report points towards a way forward by offering people more choice and control over their treatment, potentially enabling them to return to the workforce.

Fatma Mehmet, who turned to medical cannabis after her experience of living with chronic pain impacted her physical and mental health, said expanding access via the NHS can only be a good thing.

“As someone independent and career-driven, not being able to get out of bed and go to work made me feel as if my identity was being stripped away,” she said. “When I felt like I was at rock bottom and out of options, I discovered medical cannabis. I now have the ability to work, lead a team, and regain my independence.”

She added: “Expanding medical cannabis via the NHS would mean greater choice for more people, which can only be a good thing.”

The research showed that 64 per cent of respondents believe individuals with chronic illnesses should have more treatment options to help them return to work. Over half of those who have been prescribed medication said it provides little relief, while 48 per cent reported it negatively affects their quality of life.

It was reported that half of those who have not previously been prescribed medical cannabis would consider trying it if it were more widely available on the NHS.

Pushpin Singh, managing economist at the Centre for Economics and Business Research, concluded: “Our analysis shows that appropriately prescribed medical cannabis can help people with chronic conditions return to work.

“Expanding NHS access would benefit patients while delivering significant productivity gains and cost savings to the UK economy.”

Share this @internewscast.com
You May Also Like

Citalopram Users Advised to Review NHS Antidepressant Warning

The NHS has issued a warning to individuals taking one of the…

Katy Perry Shares Her Diet Secrets During Australia Visit Amid Ozempic Speculation

Katy Perry has revealed was she ate in Australia while she was Down…

Inside an Oncologist’s World: The Profound Impact of Delivering a Cancer Diagnosis

Being an oncologist often feels like navigating the delicate intersection of science…

Tesco Issues Urgent Recall of Gluten-Free Breadcrumbs Over Wheat Contamination Concerns

Tesco has announced a recall of its gluten-free white breadcrumbs due to…

Scientists Revamp Definition of ‘Obese,’ Labeling Up to 60% More People as ‘Overweight’

Up to 60 per cent more adults could be classed as obese…

Surge in NHS Waiting Lists Driven by Increased Demand for Weight-Loss Injections and Autism & ADHD Evaluations

Growing interest in weight-loss injections and evaluations for autism and ADHD has…

Important Alert: Woman’s Revelatory Diagnosis Offers Hope for Back Pain Sufferers

What started as a seemingly ordinary morning for one woman quickly turned…

Eye Movements May Predict Serious Health Conditions Years Before Symptoms Emerge

Eye-tracking technology may offer a more affordable alternative for detecting a genetic…

China’s Alarming New Virus Variant: Unveiling the Pandemic Threat Looming Worldwide

New concerns over pandemic threats are rising in China, as a novel…

Researchers Highlight Cannabis as a Vital Aid in Cancer Patient Recovery

In a groundbreaking development, scientists have unveiled a cannabis-derived medication that could…

UK Aid Cuts Risk 300,000 Preventable Deaths, Warn Charities

Anticipation is mounting in the UK as it prepares to reduce its…